Capsular polysaccharide solubilisation and combination vaccines

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/095 (2006.01) A61K 9/08 (2006.01) A61K 9/19 (2006.01) A61K 39/116 (2006.01) A61K 39/385 (2006.01) A61P 31/04 (2006.01) A61P 37/04 (2006.01)

Patent

CA 2641585

The invention comprises a kit comprising: (a) conjugated capsular saccharide from N.meningitidis serogroup A, in lyophilised form; and (b) capsular saccharides from N.meningitidis serogroups C, W135 and Y, in liquid form wherein the ratio (w/w) of serogroup A saccharide to serogroup C saccharide is greater than 1.

La présente invention concerne une trousse comprenant a) un saccharide capsulaire conjugué, sous forme lyophilisée, provenant du sérogroupe A de N. meningitidis, et b) des saccharides capsulaires, sous forme liquide, provenant des sérogroupes C, W135 et Y de N. meningitidis, dans laquelle le ratio (m/m) saccharide de sérogroupe A-saccharide de sérogroupe C est supérieur à 1.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Capsular polysaccharide solubilisation and combination vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Capsular polysaccharide solubilisation and combination vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Capsular polysaccharide solubilisation and combination vaccines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1381148

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.